| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0016-5085(93)90426-D |
| P698 | PubMed publication ID | 8381099 |
| P2093 | author name string | Liang TJ | |
| Yarbough PO | |||
| Reyes GR | |||
| Schiff ER | |||
| Jeffers L | |||
| De Medina M | |||
| Reddy RK | |||
| Cheinquer H | |||
| Silva MO | |||
| Findor A | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| P304 | page(s) | 556-562 | |
| P577 | publication date | 1993-02-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses | |
| P478 | volume | 104 |
| Q35981200 | A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India |
| Q33939738 | Acute hepatic failure: a Western perspective |
| Q40816631 | Acute hepatic failure: limitations of medical treatment and indications for liver transplantation |
| Q34095674 | Acute liver failure: established and putative hepatitis viruses and therapeutic implications |
| Q72719805 | Aplastic anemia after liver transplantation for fulminant liver failure |
| Q47753081 | Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update |
| Q40509033 | Childhood hepatitis |
| Q35960885 | Clinical manifestations of hepatitis C. |
| Q59352380 | Clinical outcome and viral genome variability of hepatitis B virus induced acute liver failure (HEP-18-0579) |
| Q43037677 | Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure |
| Q34356050 | Epidemiological characteristics, risk factors, and clinical manifestations of acute non-A-E hepatitis |
| Q43036452 | Epidemiological, clinical and biological characteristics of acute non-A, non-B hepatitis with and without hepatitis C virus infection |
| Q40695310 | Epidemiology and serologic diagnosis of hepatitis E. |
| Q43040456 | Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis |
| Q27473013 | Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis |
| Q34461102 | Fulminant Hepatitis in Children: Evidence for an Unidentified Hepatitis Virus |
| Q81544318 | Fulminant hepatic failure |
| Q33540212 | Fulminant hepatic failure |
| Q72330553 | Fulminant hepatic failure |
| Q45786533 | Fulminant hepatic failure due to hepatitis E virus |
| Q35357332 | Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus |
| Q45768210 | Fulminant hepatitis caused by hepatitis C virus during treatment for multiple sclerosis |
| Q73824104 | Fulminant hepatitis in patients undergoing liver transplantation: Evidence for a non-A, non-B, non-C, non-D, and non-E syndrome |
| Q41753401 | GBV-C/HGV: A new virus within the Flaviviridae and its clinical implications |
| Q41157498 | Hepatitis B and C viruses and primary liver cancer |
| Q34124642 | Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation |
| Q43049617 | Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study |
| Q27486836 | Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation |
| Q42989339 | Hepatitis C virus infection: Review and implications for the dentist |
| Q41225114 | Hepatitis C virus infection: clinical aspects and treatment with interferon alfa |
| Q42977564 | Hepatitis C virus-associated fulminant hepatic failure |
| Q41332828 | Hepatitis C virus: molecular biology and genetic variability |
| Q36642065 | Hepatitis C: progress and problems |
| Q72511213 | Histopathological heterogeneity in fulminant hepatic failure |
| Q27477934 | Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection |
| Q72161416 | Interferon and cyclosporin A in the treatment of fulminant viral hepatitis |
| Q43042500 | Lack of evidence for hepatitis B virus (HBV) infection in fulminant non-A, non-B hepatitis |
| Q45737952 | Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation |
| Q42993083 | Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan |
| Q33988092 | Natural history of acute hepatitis C. |
| Q71701208 | New hepatitis viruses |
| Q42985708 | Non-A, non-B, non-C hepatitis: its significance in pediatric patients and the role of GB virus-C. |
| Q38479571 | Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia |
| Q42986451 | Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan |
| Q42203624 | Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study |
| Q43942365 | Selection of prognostic factors of acute hepatitis type non-A, non-B for patient listing for liver transplantation |
| Q42653114 | Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient |
| Q42991519 | The distribution of HBV, HCV and HGV among livers with fulminant hepatic failure of different aetiology |
| Q71668964 | The natural history of hepatitis C |
| Q41574241 | The quasispecies of hepatitis C virus and the host immune response |
| Q43478980 | What are cryptogenic hepatic diseases? |
| Q72749710 | [Hepatitis C] |
Search more.